The WACC of BioCryst Pharmaceuticals Inc (BCRX) is 8.7%.
| Range | Selected | |
| Cost of equity | 7.90% - 12.80% | 10.35% |
| Tax rate | 0.10% - 0.50% | 0.30% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 6.6% - 10.8% | 8.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.88 | 1.41 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.90% | 12.80% |
| Tax rate | 0.10% | 0.50% |
| Debt/Equity ratio | 0.51 | 0.51 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 6.6% | 10.8% |
| Selected WACC | 8.7% | |